Maternal exposure to heparin products and risk of birth defects in the National Birth Defects Prevention Study
Sign Up to like & getrecommendations! Published in 2022 at "Birth Defects Research"
DOI: 10.1002/bdr2.2074
Abstract: Heparin and low‐molecular‐weight heparin are the preferred anticoagulants during pregnancy as they do not cross the placenta. Although research on the safety of heparin products has been reassuring, previous studies have considered birth defects as… read more here.
Keywords: heparin products; birth defects; maternal exposure; exposure heparin ... See more keywords
Evaluating heparin products for heparin-induced thrombocytopenia using surface plasmon resonance.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of pharmaceutical sciences"
DOI: 10.1016/j.xphs.2019.10.040
Abstract: Heparin-induced thrombocytopenia (HIT) is an adverse immunological disorder caused by antibodies to platelet factor 4 (PF4)-heparin complexes. The analysis of HIT potential for different heparin and heparin-related products is important prior to their clinical application.… read more here.
Keywords: heparin; heparin products; using surface; induced thrombocytopenia ... See more keywords